Status:
UNKNOWN
Atrial Fibrillation Research Database
Lead Sponsor:
University of Campania Luigi Vanvitelli
Collaborating Sponsors:
Monaldi Hospital
Conditions:
Anticoagulants and Bleeding Disorders
Atrial Fibrillation
Eligibility:
All Genders
18-110 years
Brief Summary
All patients with atrial fibrillation who are treated with vitamin-k antagonists (warfarin, phenprocoumon) or non vitamin K oral anticoagulants (Dabigatran, Rivaroxaban, Apixaban, Edoxaban) in real wo...
Eligibility Criteria
Inclusion
- Patients with atrial fibrillation
- Indication for oral anticoagulant treatment
Exclusion
- Missing Informed Consent Form
- Missing Contact Informations for Follow up
Key Trial Info
Start Date :
June 13 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2023
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT03760874
Start Date
June 13 2013
End Date
January 1 2023
Last Update
June 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Campania "Luigi Vanvitelli"
Naples, Italy